Market capitalization | $11.53b |
Enterprise Value | $19.55b |
P/B ratio (TTM) P/B ratio | 3.61 |
Cash position | $772.00m |
P/E forward | 21.58 |
P/S forward | 1.40 |
EV/Sales forward | 2.37 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
12 Analysts have issued a Solventum forecast:
12 Analysts have issued a Solventum forecast:
Sep '24 |
+/-
%
|
||
Revenue | 2,082 2,082 |
0%
0%
|
|
Gross Profit | 1,165 1,165 |
4%
4%
|
|
EBITDA | 408 408 |
37%
37%
|
EBIT (Operating Income) EBIT | 275 275 |
45%
45%
|
Net Profit | 122 122 |
73%
73%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.
Head office | United States |
CEO | Bryan Hanson |
Employees | 22,000 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.